EYP-1901 shows promising results in reducing treatment burden for diabetic macular edema, offering sustained improvements in vision and safety.
Carl D. Regillo, MD, FACS, FASRS
Advertisement
Articles by Carl D. Regillo, MD, FACS, FASRS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Frank Holz, MD, FEBO, FARVO, highlights new treatment developments at EURETINA
2
Challenges Reported by Young Physicians in Managing Geographic Atrophy and How these Shape Patient Care
3
Q&A: The ARCHER trial and the importance of continued GA research
4
The Retina TL;DR: Advancing sustained VEGF suppression with EYP-1901 with Jay S. Duker, MD
5
